Press releases
- Press releases
- Browse
Press releases
Excellence Recognized for Pharmalicensing's Industry Information, Company and Technology Profiles, and Impressive Number of Deals Done More
New edition of report on opportunities in Indian pharma and biotech features partnering opportunities in companies, life science research institutes and biotech parks More
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
Pharmalicensing launches revised versions of its Deals Briefings with up-to-date data More
New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
BIO BALANCE and DSS Systems & Software Technologies Ltd. complete development of a prototype program
BIO BALANCE'S biophysical model for the initial receptor response More
Partneringdesk Deals and Alliances therapy reports are revised with up-to-date deals More
New agreement in Animal Health area More
Drug desensitization is an overlooked side effect of many drugs. Desensitization often contributes to a person's inability to tolerate many common medications including those for the heart, pain or asthma. More
New edition of Partneringreview summarizes pharma and biotech deals of 2005 More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jun 2006 - 1068 pages - $2,495
Oct 2010 - 53 pages - $1,000
Aug 2011 - 8 pages - $75
Aug 2011 - 7 pages - $75
Sep 2011 - 97 pages - $3,500
Feb 2011 - 75 pages - $1,000
Aug 2011 - 7 pages - $75
Aug 2011 - 7 pages - $75
Aug 2011 - 8 pages - $75
Aug 2006 - 8 pages - $1,000
Your selection
Browse By
- Industry sector
- Antibodies
- Antigens
- Biomarkers
- Cell lines
- Mouse models
- Reagents
- Vectors
- Therapeutic target
- Age-related disorders (other)
- Amyotrophic lateral sclerosis
- CNS (other)
- Neurodegenerative disorders
- Neurological
- Pain
- Psychiatric
- Subarachnoid hemorrhage
- Traumatic brain injury
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us